FibroGen

0 followers

FibroGen, Inc. is a science-based biopharmaceutical company discovering and developing a pipeline of first- in-class therapeutics. The Company is focused on fibrosis and hypoxia-inducible factor (HIF) biology and clinical development to advance innovative medicines for the treatment of anemia, fibro... Read more

Industries

Employees

501-1,000

Links


Org chart

Percy H. Carter
Chief Scientific Officer
Christine L. Chung
SVP, China Operations
Pat Cotroneo
Executive Advisor To Chief Executive Officer
Elias Kouchakji
SVP, Clinical Development, Drug Safety, and Pharmacovigilance
Michael D. Lowenstein
Chief Legal Officer
Leanne C. Price
Chief Intellectual Property Officer
Thane Wettig
Chief Executive Officer
Dr. Olga V. Gambetti M.D., Ph.D., Drmedsci
Medical Director, Clinical Development
Lori S.
Executive Medical Director, Clinical Development
Robin Matthew M.D., Mha, Jd (expected)
Medical Writer (regulatory Affairs)
Aileen Huang (Cuihua)
Sr. Medical Manager
Dennis Kim
Associate Director, IT Operations
Max
IT Manager
Van Pell Gerard
IT Operations Manager
Dana Fong
Director, IT Business Integrations
Faeq Mansour
Senior Director, Head Of IT
Jack Li
Sr Director Biostatistics
Mark Lonergan
Vice President, Manufacturing And Supply Operations
Chris Newman
Executive Director Business Development
Carol Gaddum
Executive Director, Product Team Lead
Claudia Witschi
Executive Director, Head Analytical Development And Drug Product
Bernardo Lomongsod
Associate Scientist 1
Dongxia Li
Principal Scientist
Elena Vaisberg
Associate Scientist
Gerardo Pangilinan Ms, Dabt
Principal Scientist
Gihani Wijewickrama
Principal Scientist CMC Analytical Development In Biologics
Guangjie Guo
Senior Scientist
Jung Min Park
Sr Scientist
Zhao Hongda
Scientist
Tricia Stewart
Chief People Officer